http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016168198-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_285f828afcbe0d96d2963238e7b793ef
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-735
filingDate 2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12753f0307b4abc299ada886c6bd2211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f9e0c10b696c2ed0295227d7712376
publicationDate 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016168198-A1
titleOfInvention Epidermal growth factor receptor variant iii-mesothelin fusions and methods of using the same
abstract Provided herein are compositions and methods for eliciting an immune response in a subject. In particular, the present disclosure is directed to fusion proteins comprising an epidermal growth factor receptor variant III (EGFRvIII) polypeptide and a mesothelin polypeptide, and methods of eliciting an immune response using host cells comprising nucleic acid molecules encoding said fusion proteins. In some embodiments, the nucleic acid molecules can encode an EGFRvIII-mesothelin fusion protein comprising an amino acid sequence that is at least i) 90% identical, ii) 95% identical, or iii) 99% identical to EGFRvIIIx5-mesothelin35-622 as set forth in SEQ ID NO:8.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11183286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10055540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11264117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847252-B2
priorityDate 2015-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014037662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014186387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2808035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014315314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004018999-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012068360-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492964

Total number of triples: 51.